L-threo-a-D-galacto-Octopyranoside, methyl7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-
CAS: 18323-44-9
Ref. IN-DA01DOXA
10mg | Descatalogado | ||
50mg | Descatalogado | ||
250mg | Descatalogado | ||
500mg | Descatalogado |
Información del producto
Nombre:
L-threo-a-D-galacto-Octopyranoside, methyl7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-
Sinónimos:
- [u'7 Chloro 7 deoxylincomycin', u'7-Chloro-7-deoxylincomycin', u'Chlolincocin', u'Chlorlincocin', u'Cleocin', u'Clindamycin', u'Clindamycin Hydrochloride', u'Clindamycin Monohydrochloride', u'Clindamycin Monohydrochloride, Monohydrate', u'Dalacin C', u'Hydrochloride, Clindamycin', u'Monohydrate Clindamycin Monohydrochloride', u'Monohydrochloride, Clindamycin', u'Monohydrochloride, Monohydrate Clindamycin', u'clindamycin', u'18323-44-9', u'Chlolincocin', u'Dalacine', u'Clindamicina', u'Clindamycinum', u'Clinimycin', u'Dalacin C', u'Sobelin', u'Clindamycine', u'UNII-3U02EL437C', u'7-Chlorolincomycin', u'7-Chloro-7-deoxylincomycin', u'Klimicin', u'7(S)-Chloro-7-deoxylincomycin', u'ClindaDerm', u'3U02EL437C', u'7-CDL', u'U 21251', u'Klindan 300', u'Antirobe', u'7-Deoxy-7(S)-chlorolincomycin', u'C18H33ClN2O5S', u'HSDB 3037', u'U-21251', u'EINECS 242-209-1', u'(2S,4R)-N-((1S,2S)-2-chloro-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)propyl)-1-methyl-4-propylpyrrolidine-2-carboxamide', u'methyl 7-chloro-6,7,8-trideoxy-6-{[(4R)-1-methyl-4-propyl-L-prolyl]amino}-1-thio-L-threo-alpha-D-galacto-octopyranoside', u'U-21,251', u'Clindamycin [USAN:INN:BAN]', u'SR-05000001477', u'Clindamycin,(S)', u'(2S,4R)-N-[(1S,2S)-2-chloranyl-1-[(2R,3R,4S,5R,6R)-6-methylsulfanyl-3,4,5-tris(oxidanyl)oxan-2-yl]propyl]-1-methyl-4-propyl-pyrrolidine-2-carboxamide', u'(2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)-2-oxanyl]propyl]-1-methyl-4-propyl-2-pyrrolidinecarboxamide', u'(2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyl-tetrahydropyran-2-yl]propyl]-1-methyl-4-propyl-pyrrolidine-2-carboxamide', u'L-threo-alpha-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, (2S-trans)-', u'CLDM', u'NSC305832', u'Clindamycin (USAN/INN)', u'AC1L9JV8', u'SCHEMBL3154', u'CHEMBL1753', u'CLINDA & IL-12', u'BIDD:GT0418', u'Clindamycin & Interleukin 12', u'DTXSID2022836', u'KDLRVYVGXIQJDK-AWPVFWJPSA-N', u'HMS2089A05', u'HMS2089N16', u'L-threo-alpha-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-((((2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-', u'L-threo-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-, trans-alpha-', u'ZINC4038341', u'2327AH', u'CC0170', u'AM84752', u'API0002057', u'DB01190', u'CS-11147', u'L-threo-.alpha.-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-', u'C06914', u'D00277', u'AB01275425-01', u'AB01275425_02', u'323C449', u'A812757', u'A831786', u'SR-05000001477-1', u'(2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide', u'methyl 7-chloro-6,7,8-trideoxy-6-({[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl}amino)-1-thio-L-threo-alpha-D-galacto-octopyranoside', u'Cleocin', u'Clindamycin Hcl']
- (2S,4R)-N-[2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyl-tetrahydropyran-2-yl]propyl]-1-methyl-4-propyl-pyrrolidine-2-carboxamide
- 7(S)-Chloro-7-deoxylincomycin
- 7-Cdl
- 7-Chloro-7-deoxylincomycin
- 7-Chlorolincomycin
- 7-Deoxy-7(S)-chlorolincomycin
- <span class="text-smallcaps">L</smallcap>-threo-<smallcap>D</smallcap>-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-4-propyl-<smallcap>L</span>-2-pyrrolidinecarboxamido)-1-thio-, trans- α-
- <span class="text-smallcaps">L</smallcap>-threo-α-<smallcap>D</span>-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-, (2S-trans)-
- <span class="text-smallcaps">L</smallcap>-threo-α-<smallcap>D</span>-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-
- Ver más sinónimos
- Antirobe
- Chlolincocin
- Cleocin
- Clincin
- ClindaDerm
- Clindam
- Clindamicina
- Clindamycine
- Clinimycin
- Dalacin C
- Dalacin V
- Dalacine
- Klimicin
- Klindan 300
- L-threo-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-, trans- α-
- L-threo-α-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-, (2S-trans)-
- L-threo-α-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-
- Methyl (7xi)-7-chloro-6,7,8-trideoxy-6-{[(4R)-1-methyl-4-propyl-L-prolyl]amino}-1-thio-D-glycero-alpha-D-galacto-octopyranoside
- Methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-<span class="text-smallcaps">L</smallcap>-threo-α-<smallcap>D</span>-galacto-octopyranoside
- Sobelin
- U 21251
- methyl (5xi)-7-chloro-6,7,8-trideoxy-6-{[(4R)-1-methyl-4-propyl-L-prolyl]amino}-1-thio-L-glycero-alpha-D-galacto-octopyranoside hydrochloride
- methyl 7-chloro-6,7,8-trideoxy-6-{[(4R)-1-methyl-4-propyl-L-prolyl]amino}-1-thio-L-threo-alpha-D-galacto-octopyranoside
- methyl 7-chloro-6,7,8-trideoxy-6-{[(4R)-1-methyl-4-propyl-L-prolyl]amino}-1-thio-beta-L-arabino-octopyranoside hydrochloride
- Methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-L-threo-α-D-galacto-octopyranoside
- Clindamycin
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Indagoo
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
424.9830
Fórmula:
C18H33ClN2O5S
Pureza:
99%
Color/Forma:
Solid
InChI:
InChI=1S/C18H33ClN2O5S/c1-5-6-10-7-11(21(3)8-10)17(25)20-12(9(2)19)16-14(23)13(22)15(24)18(26-16)27-4/h9-16,18,22-24H,5-8H2,1-4H3,(H,20,25)/t9-,10+,11-,12+,13-,14+,15+,16+,18+/m0/s1
Clave InChI:
KDLRVYVGXIQJDK-AWPVFWJPSA-N
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS: